ABSTRACT -A serum factor (SF), isolated from acidified sera of normal donors, inhibited phytohemagglutinin (PHA) stimulation of lymphocytes isolated from patients with chronic lymphocytic leukemia (Cll), but had no effect on those from healthy donors. An SF isolated by an identical procedure from the sera of patients with Cll had essentially no inhibitory effect on DNA synthesis in normal or leukemic lymphocytes. The SF was isolated from sera or plasma by ammonium sulfate precipitation, acidification to pH 1.5, and chromatography on DEAE-cellulose. The SF was heat labile and sensitive to digestion by trypsin. Maximum inhibition was obtained when the factor was added within 24 hours after the cells were stimulated with PHA.-J Natl Cancer Inst 57: 217-220, 1976. Numerous components in serum contribute to the regulation of growth of cultured cells (l, 2). Some of these components promote proliferation or are necessary for cell survival (1, 3, 4), whereas others inhibit cell growth (5-7). While studying a factor that supported the survival of cultured mouse cells, Lipton et al. (4) found that acidified serum liberated a substance that inhibited the growth and survival of cultured SV3T3 cells. Paul (6) extended this observation and demonstrated that several virus-transformed cell lines were inhibited by this "cytotoxic" SF, whereas their nontransformed counterparts were unaffected. In the presence of serum, used routinely to support growth, the SF was less effective than when added to cells maintained in serum-free media. Paul (6) also demonstrated that this factor can be isolated from the sera of rats, mice, guinea pigs, and horses, and it has inhibitory activity against the ascites form of the myeloma XS63.5 and lymphoma SI tumors grown in mice.
Numerous components in serum contribute to the regulation of growth of cultured cells (l, 2). Some of these components promote proliferation or are necessary for cell survival (1, 3, 4) , whereas others inhibit cell growth (5) (6) (7) . While studying a factor that supported the survival of cultured mouse cells, Lipton et al. (4) found that acidified serum liberated a substance that inhibited the growth and survival of cultured SV3T3 cells. Paul (6) extended this observation and demonstrated that several virus-transformed cell lines were inhibited by this "cytotoxic" SF, whereas their nontransformed counterparts were unaffected. In the presence of serum, used routinely to support growth, the SF was less effective than when added to cells maintained in serum-free media. Paul (6) also demonstrated that this factor can be isolated from the sera of rats, mice, guinea pigs, and horses, and it has inhibitory activity against the ascites form of the myeloma XS63.5 and lymphoma SI tumors grown in mice.
We describe here the isolation and some characteristics of an SF obtained from the sera of healthy donors. It inhibits DNA synthesis in stimulated lymphocytes from patients with CLL but not from healthy donors.
MATERIALS AND METHODS
Lymphocytes from normal donors and patients with CLL were prepared as described in (8, 9) . Peripheral blood lymphocytes were separated from other blood cells on Ficoll-Hypaque gradients, washed two times with Eagle's minimum essential medium, resuspended in McCoy's 5-A medium, and counted. McCoy's 5-A medium was supplemented with either 10% (vol/vol) autologous serum or 10% (vol/vol) FCS. The growth characteristics of stimulated normal and CLL lymphocytes were essentially the same in autologous serum or FCS. The medium was supplemented with antibiotics (penicillin and slreptomycin) and L-glutamine. Usually, 1 U blood (500 ml) in CPD was processed for each normal donor, and 50 ml blood collected in heparin from each patient with CLL. The preparation of the SF and its inhibitory activity on cell growth were unaffected by the use of either CPD or heparin.
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The 5 patients in this study had not been treated for CLL, and their leukocyte counts ranged from 37,000 to 55,000/mm 3 , with a differential of 78-95% smalilymphocytes. After resolution on Ficoll-Hypaque gradients, the lymphocyte preparations from normal donors and CLL patients contained greater than 90 and 95% small lymphocytes, respectively. The serum or plasma was frozen at -20° C and fractionated at a later date for SF activity.
Normal and CLL cultures contained 2x 10 6 lymphocytes/ml in a total volume of 20 ml and were stimulated with 40 p.g PHAjl07 cells (pHA-P; Difco Laboratories Inc., Detroit, Mich.) as described in (10) . DNA synthesis was followed by pulse labeling with 0.5 p.Ci [3H]thymidine (2.0 Ci/mmole; New England Nuclear Corp., Boston, Mass.) per ml for 2 hours at the times indicated. The cells were centrifuged (2,000Xg for 10 min), the media removed, and 5 ml cold (4° C) trichloroacetic acid was added to the cell pellets. The cells were resuspended on a Vortex mixer, and the precipitate was allowed to settle for 24 hours (4° C) and collected on 0.45-p. filters (Millipore Corp., Bedford, Mass.). The filters were dried at room tern perature, placed in vials containing 10 ml Aquasol (New England Nuclear Corp.), and counted. DNA content was determined by the procedure described by Burton (11) .
SF was prepared by the technique described by Paul (6). Normal or CLL serum or plasma was precipitated by the addition of ammonium sulfate (40% saturation). The precipitate was dissolved in water and dialyzed against 40 volumes of isotonic saline (0.9% NaCl) for 24 hours at 4° C. This fraction was brought to room temperature, acidified with 0.1 N HCl to pH 1.5, allowed to stand for 10 minutes, and then neutralized with 0.1 N NaOH. The precipitate was then discarded and the supernatant dialyzed against 40 volumes of water (4° C) for 24 hours. The dialyzed material was lyophilized, redissolved in a minimum amount of buffer (0.01 M Tris-HCl, pH 7.4), and c'hromatographed on DEAE-70-cellulose (Whatman Inc., Clifton, N.J.). The material was applied to a 1.5X90-cm column, which bound approximately 10 mg protein/ml. The DEAE-cellulose column was washed extensively with 200-300 ml buffer to remove nonbound protein. Then a O-l-M NaCI gra-ABBREVIATIONS USED: SF=serum factor; CLL=chronic lymphocytic leukemia; FCS=fetal calf serum; CPD=citrate-phosphate-dextrose; PHA=phytohemagglutinin; PBS=phosphate-buffered saline; BSA = bovine serum albumin. dient (in 0.01 M Tris-HCl, pH 7.4) was applied and a second protein peak was eluted. This fraction was dialyzed against 40 volumes of water (24 hr, 4° C), lyophilized, dissolved in either Dulbecco's PBS or McCoy's 5-A medium, and sterilized by filtration (0.22-/L filter; Millipore Corp.) before assay for inhibitory activity. Protein determinations were done by the method described by Lowry et al. (12) .
The material eluted from the DEAE-cellulose column was submitted to heat denaturation and trypsin digestion. SF was dissolved in PBS and placed in a boiling water bath (100° C) for 5 minutes; then the sample was cooled to 4° C. The precipitate was removed by centrifugation (3,000Xg, 10 min, 4° C) and the supernatant assayed in both normal and CLL cultures for inhibitory activity. The SF (14 mg protein/ml PBS) was digested with 0.64 U trypsin/mg (Enzite trypsin; Miles Laboratories, Elkhart, Ind.) for 1 hour at 37° C. Enzite trypsin was removed by centrifugation (3,000 Xg, 10 min, 4° C), and the digested material was sterilized by filtration (0.22-/L filter; Millipore Corp.) and assayed in normal and CLL cultures.
RESULTS AND DISCUSSION
Two peaks of protein were obtained from the ammonium sulfate and acidified fractions of serum or plasma after chromatography on DEAE-cellulose (text- fig. 1 ). A O-LO-M NaCI gradient was then applied and a large protein-containing peak was eluted. The total protein recovered in this peak (fractions 50-80) after dialysis and lyophilization was approximately 80-85% of the total protein applied, and in this experiment was 213 mg protein. The column eluate was monitored at 280 nm with an ISCO UA5 absorbance monitor (Instrument Specialties Co., Lincoln, Nebr.); the pattern obtained from one normal donor is shown. Fractionated sera from all normal donors and patients with CLL had elution patterns essentially identical to the one presented here.
DEAE-CELLULOSE CHROMATOGRAPHY OF SF
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The first peak was eluted with buffer (0.01 M Tris-HCl, pH 7.4) and contained no inhibitory activity when added to PHA-stimulated lymphocytes. A second peak (containing 80-85% of the total protein applied to the column) was eluted between 0.3 and 0.6 M NaC!, and it contained all the inhibitory activity (text- fig. 2 ). Similar elution patterns were obtained from the serum or plasma from both normal and CLL donors, but only the SF produced from healthy donors had significant inhibitory activity (text- figs. 2, 3) . The SF was completely inactivated by boiling or proteolytic digestion with trypsm. The typical effect of SF on PHA-stimulated CLL lymphocytes is shown in text-figure 2. Maximum DNA synthesis in PHA-stimulated CLL lymphocytes occurred approximately 120 hours after addition of the mitogen. In contrast, treatment of CLL lymphocytes with 1.0 mg protein/ml (peak 2 of text- fig. 1 ) immediately after the addition of PHA almost completely inhibited the blastogenic response. The inhibition was dose-dependent over a range of 0.1-1.0 mg (text- fig. 4 ). Less than 0.1 mg SF had essentially no effect.
Text- figure 5 demonstrates the effects of adding SF at daily intervals after mitogenic stimulation. The inhibition was most pronounced when the SF was added within 24 hours after PHA. However, the addition of SF to cells at any time period prevented subsequent DNA synthesis.
Text- figure 3 shows that the addition of SF from the sera of patients with CLL over a concentration range of 0.1-1.0 mg/ml had little or no effect on PHA-stimu- The data presented here demonstrate that an SF, apparently analogous to the ones isolated from animal sera that demonstrate toxicity to virus-transformed murine cells (6) , can be obtained from the sera of healthy human donors. This factor is inhibitory to PHA-stimulated lymphocytes from patients with CLL, but fractions isolated by identical procedures from the sera of individuals with CLL have no inhibitory activity. The activation or release of factors by the acidification of normal serum is of interest because these substances may exist in precursor form in the circulation and when activated, presumably enzymatically, function in the regulation of cell growth.
Furthermore, the SF investigated here had no effect on normal lymphocyte growth; this suggested that it may monitor neoplastic cell growth. Murine SF's also exhibit such a role, as demonstrated by their ability to inhibit virus-transformed fibroblasts but not the growth VOL. 57, NO of uninfected fibroblasts. The degree of cell selectivity by these inhibitory factors has not been determined.
